As biologically inspired nanocarriers, virus-like particles combine safety with functional adaptability. Their capacity for modular design supports innovation in immunotherapy, targeted drug delivery, and advanced diagnostic technologies. The global virus-like particles market is entering a phase of sustained expansion, with projected growth from US$ 6.25 billion in 2025 to US$ 12.15 billion by...